Exclusive Fasttrak - Apply to clinical trial testing a new immunotherapy for prostate cancer!

[Darryl]

What if you could get access to free immunotherapy treatment using Nivolumab, also known as OPDIVO? Opdivo is used for other cancer types, but has not yet been approved for prostate cancer.

Opdivo is a medicine that may treat certain cancers by working with your immune system. Malecare, along with our partners, is prescreening our community for a study of Nivolumab or Placebo in Combination With Docetaxel in men With Advanced Castration-resistant Prostate Cancer. Using a novel prescreening method, applying through Malecare might Fastrack your application. If you meet the following criteria, please go to malecare.org/clinical-trial to start your inquiry.

You must be metastatic (either regional lymph nodes or distant mets and can include bone mets)

You must be castration-resistant and receiving ongoing ADT therapy or have undergone bilateral orchiectomy

You must be chemotherapy naïve (never received chemotherapy) FOR METASTATIC DISEASE and have received 1 hormone therapy (ex. Abiraterone, enzalutamide, apalitamide, darolutamide, etc) in the metastatic setting (can have received up to 2 hormonal therapies in the non-metastatic setting)

You must live in either the USA or Canada

Start your inquiry even if you are not sure that you qualify: malecare.org/clinical-trial

[GoBucks]

Curious why these trials don't seek out castrate sensitive patients. Why not try things earlier?

[Darryl Partner in reply to GoBucks]

I empathize with your concern and question. For now, we have this trial, which I believe will help many of those who enter.

[Stevana in reply to GoBucks]

Go Bucks,See my earlier post to Darryl. There is a trial available for mHSPC.

[Yank66]

What is the location of the trial?

[Darryl Partner in reply to Yank66]

There are several dozen trial sites. I'll list those on the webpage later today. It should be convinient for most USA residents and slighly less for Canadians.

[Darryl Partner in reply to Yank66]

I've added the sites list to the webpage malecare.org/clinical-trial

[Stevana]

For all who may be interested - I am currently in a clinical trial designed for mHSPC thru Dana-Farber with treatments administered thru Moffitt Cancer Center in Tampa, Fl.

I have completed my chemotherapy + Opdivo (Nivolumab) part of the trial and I’m now in the Opdivo phase only. I can attest that I have experienced little to no side effects from the Opdivo treatment thus far. I will post if this changes. I’m expected to remain on a four week regimen of infusions over the next 24 months, with intermittent body scans. Will let you know how things progress, but for now things are going pretty smoothly. I’m stage four with multiple mets, but asymptomatic. If it wasn’t for ADT (Firmagon) I wouldn’t know I have APC. The best to all. Keep fighting. 💪

[GoBucks in reply to Stevana]

That trial looks like it excludes patients who had prostatectomy and those who have had zytiga. But at least someone is offering trials to hormone sensitive patients.

[Darryl Partner in reply to GoBucks]

You are referring to the trial Stevana mentioned, not to the trial that Malecare is developing.

[GoBucks in reply to Darryl]

Correct.

[Darryl Partner]

I've added the sites list to the webpage malecare.org/clinical-trial